Sanjad-Sakati Syndrome

Mendelian MONDO:0009426 Pathograph 25 Show in embeddings browser Autosomal recessive disease Primordial dwarfism

Sanjad-Sakati syndrome (HRD) is an autosomal recessive disorder of congenital hypoparathyroidism, severe pre- and postnatal growth failure, microcephaly, characteristic dysmorphism and intellectual disability, reported almost exclusively in populations of the Arabian peninsula and the wider Middle East, where a founder 12-bp deletion in TBCE accounts for most cases. TBCE encodes one of the chaperones that fold alpha-tubulin and build alpha-beta tubulin heterodimers, so this is a chaperone disease of the tubulin assembly pathway rather than a primary parathyroid gene defect - the parathyroid link runs through microtubule-dependent secretory traffic. The same gene, at the more severe end of its allelic spectrum, causes autosomal recessive Kenny-Caffey syndrome, which adds osteosclerosis and recurrent bacterial infection; the two share an ancestral haplotype. Neonatal presentation is usually hypocalcemic seizures or apnea, and mortality is high, driven by pneumonia and sepsis.

Ask OpenScientist

Ask a research question about Sanjad-Sakati Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
6
Pathophys.
16
Phenotypes
25
Pathograph
1
Genes
3
Medical Actions
1
Models
7
References
1
Deep Research
🏷

Classifications

Harrison's Part
GENETICS ENVIRONMENT DISEASE ENDOCRINOLOGY METABOLISM
ISDS Skeletal Nosology
primordial dwarfism and slender bones
👪

Inheritance

1
Autosomal recessive HP:0000007
Biallelic TBCE variants. In the Kuwaiti series every affected individual was homozygous for the 12-bp founder deletion and every parent was a heterozygous carrier.
Autosomal recessive inheritance
Show evidence (1 reference)
PMID:19554981 SUPPORT Human Clinical
"All affected persons had homozygous deletion of 12 bp (155-166del) in exon 3 of the TBCE gene. All of the parents were heterozygous carriers of this mutation."
Homozygosity in all affected individuals with obligate carrier parents is the classic autosomal recessive segregation pattern.
⚙

Pathophysiology

6
Loss of Tubulin-Folding Cofactor E
Biallelic deletion or truncation of TBCE removes one of the chaperones required to fold alpha-tubulin subunits and assemble them into alpha-beta tubulin heterodimers. The primary lesion is therefore in the tubulin supply chain, not in any parathyroid-specific pathway - which is what makes this a chaperone disease.
TBCE hgnc:11582 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves TBCE (hgnc:11582). hgnc:11582 is a gene from the HUGO Gene Nomenclature Committee.
tubulin complex assembly GO:0007021 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased tubulin complex assembly (GO:0007021). GO:0007021 is a biological process from the Gene Ontology. ↓ DECREASED protein folding GO:0006457 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased protein folding (GO:0006457). GO:0006457 is a biological process from the Gene Ontology. ↓ DECREASED
Animal models
pmn/pmn mouse (Tbce p.Trp524Gly) Mouse recapitulates A destabilizing missense allele reducing Tbce protein, complemented by a wild-type transgene - the causal relationship is established rather than correlative.
Downstream
Reduced Microtubule Density and Perturbed Polarity
Show evidence (1 reference)
PMID:12389028 SUPPORT Human Clinical
"The gene TBCE encodes one of several chaperone proteins required for the proper folding of alpha-tubulin subunits and the formation of alpha-beta-tubulin heterodimers."
States the molecular function whose loss initiates the disease.
Reduced Microtubule Density and Perturbed Polarity
Patient fibroblasts and lymphoblastoid cells show lower microtubule density at the microtubule-organizing centre and disturbed microtubule polarity - the direct cellular readout of an inadequate supply of folded tubulin heterodimers.
dermal fibroblast CL:0000057 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves dermal fibroblast, annotated with fibroblast (CL:0000057). CL:0000057 is a cell type from the Cell Ontology.
microtubule cytoskeleton organization GO:0000226 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased microtubule cytoskeleton organization (GO:0000226). GO:0000226 is a biological process from the Gene Ontology. ↓ DECREASED
Animal models
pmn/pmn mouse (Tbce p.Trp524Gly) Mouse recapitulates Microtubule loss is demonstrated directly in mutant nerve, and the later study localizes TBCE to the Golgi and shows that microtubule loss proceeds retrogradely in step with axonal dying back - a cell-biological account of the cytoskeletal defect that the human patient-cell data can only measure statically.
Downstream
Disturbed Microtubule-Dependent Membrane Trafficking
Microcephaly Microtubule-dependent neural progenitor division is the plausible route to reduced brain growth; the specific requirement in neural progenitors has not been demonstrated for TBCE.
Intellectual disability Grouped with the microcephaly as a neurodevelopmental consequence of the cytoskeletal defect; the route is not established.
Combined Immunodeficiency Lymphocyte activation and division are microtubule-dependent, and the same lymphoblastoid cells that carry the measured microtubule defect are the ones that proliferate poorly - but no study has shown the immunological deficit to follow from the cytoskeletal one in this disorder, so the edge is drawn as an inference.
Show evidence (1 reference)
PMID:12389028 SUPPORT In Vitro
"Analysis of diseased fibroblasts and lymphoblastoid cells showed lower microtubule density at the microtubule-organizing center (MTOC) and perturbed microtubule polarity in diseased cells."
The measured cytoskeletal defect in patient cells.
Disturbed Microtubule-Dependent Membrane Trafficking
Organelles that depend on microtubules for membrane trafficking - the Golgi and the late endosomal compartment - are structurally disturbed in patient cells. This is the step that plausibly connects a general cytoskeletal defect to a secretory endocrine organ, and the authors propose it as a link between tubulin physiology and parathyroid development. It remains a proposal: no study has shown parathyroid-specific trafficking failure directly.
Golgi organization GO:0007030 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal Golgi organization (GO:0007030). GO:0007030 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Golgi apparatus GO:0005794 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves Golgi apparatus (GO:0005794). GO:0005794 is a cellular component from the Gene Ontology.
Animal models
pmn/pmn mouse (Tbce p.Trp524Gly) Mouse partially recapitulates The model supplies the mechanistic content this node otherwise lacks: TBCE is a peripheral membrane protein at the Golgi, and disrupting the Golgi pharmacologically phenocopies the mutation's effect on tubulin routing. That makes a Golgi-centred trafficking defect a demonstrated mechanism in neurons rather than only a proposal.
Downstream
Parathyroid Failure and Congenital Hypoparathyroidism
Severe Pre- and Postnatal Growth Failure
Chronic intestinal pseudo-obstruction Enteric neuromuscular function depends on microtubule-based transport; grouped here as the most plausible route, though it has not been shown directly in this disorder.
Show evidence (2 references)
PMID:12389028 SUPPORT In Vitro
"Immunofluorescence and ultrastructural studies showed disturbances in subcellular organelles that require microtubules for membrane trafficking, such as the Golgi and late endosomal compartments."
Documents the trafficking-organelle disturbance downstream of the microtubule defect.
PMID:12389028 SUPPORT In Vitro
"establish a potential connection between tubulin physiology and the development of the parathyroid"
The parathyroid link is offered as a potential connection, not a demonstrated one - hence PARTIAL, and hence the hedge in this node's description.
Parathyroid Failure and Congenital Hypoparathyroidism
Congenital hypoparathyroidism with persistent hypocalcemia, present in every reported patient and typically declaring itself in the neonatal period as a hypocalcemic seizure or apnea. Chronic calcium and vitamin D therapy is itself a source of morbidity through nephrocalcinosis.
parathyroid chief cell CL:0000446 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves parathyroid chief cell, annotated with chief cell of parathyroid gland (CL:0000446). CL:0000446 is a cell type from the Cell Ontology.
parathyroid gland UBERON:0001132 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in parathyroid gland (UBERON:0001132). UBERON:0001132 is an anatomical location from the Uberon multi-species anatomy ontology.
Animal models
pmn/pmn mouse (Tbce p.Trp524Gly) Mouse fails to recapitulate pmn mice have no reported hypoparathyroidism. The defining endocrine feature of the human disease is absent from the only Tbce model, so the step from a general cytoskeletal defect to selective parathyroid aplasia has no animal support.
Downstream
Congenital hypoparathyroidism The endocrine endpoint of parathyroid failure.
Hypocalcemia PTH deficiency is the direct cause of the hypocalcemia.
Nephrocalcinosis Largely iatrogenic: a consequence of the chronic calcium and vitamin D therapy that the hypoparathyroidism requires, rather than of the primary lesion.
Show evidence (1 reference)
PMID:19554981 SUPPORT Human Clinical
"All patients had severe intrauterine growth retardation, short stature, small hands and feet, blue sclera, deep-set eyes, microcephaly, persistent hypocalcaemia and hypoparathyroidism."
Present in all 21 patients in the Kuwaiti series.
Combined Immunodeficiency
HRD is not a syndromic disease that happens to get infections - the immune defect is itself part of the disorder, and it is the main cause of death. A dedicated immunological workup of nine patients found abnormalities in both arms: a humoral defect (high total IgA and IgE but poor anti-pneumococcal titres despite routine vaccination, fewer naive B cells, expanded CD21-low CD27-negative B cells) and a cellular defect (inverted CD4/CD8 ratios, reduced terminally differentiated effector memory CD8 cells, and impaired PHA-induced proliferation in every patient). Neutrophil superoxide production and chemotaxis were normal, which locates the deficit in lymphocytes rather than in innate effector function.
T cell CL:0000084 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves T cell (CL:0000084). CL:0000084 is a cell type from the Cell Ontology. B cell CL:0000236 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves B cell (CL:0000236). CL:0000236 is a cell type from the Cell Ontology.
lymphocyte proliferation GO:0046651 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased lymphocyte proliferation (GO:0046651). GO:0046651 is a biological process from the Gene Ontology. ↓ DECREASED humoral immune response GO:0006959 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal humoral immune response (GO:0006959). GO:0006959 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Downstream
Recurrent severe infections The clinical expression of the combined deficit, and the leading cause of death in infancy.
Impaired specific antibody response The measured humoral component - vaccination does not produce protective anti-pneumococcal titres.
Abnormal T cell subset distribution The measured cellular component.
Show evidence (3 references)
PMID:36258138 SUPPORT Human Clinical
"HRD is a combined immunodeficiency disease with syndromic features, manifesting in severe invasive bacterial and viral infections."
States the conclusion this node asserts - that the immunodeficiency is a defining component of the disorder rather than a complication of it.
PMID:36258138 SUPPORT Human Clinical
"All patients had abnormal T-cell population distributions, including reduced terminally differentiated effector memory CD8, inverted CD4/CD8 ratios, and impaired phytohemagglutinin (PHA)-induced lymphocyte proliferation."
The cellular arm, in all nine patients studied.
PMID:36258138 SUPPORT Human Clinical
"Neutrophil superoxide production and chemotaxis were normal in all patients tested."
A negative result that localizes the defect to lymphocytes and excludes a neutrophil functional disorder.
Severe Pre- and Postnatal Growth Failure
Extreme growth failure beginning in utero, with microcephaly and the characteristic dysmorphism, and without catch-up - the feature that places this disorder among the primordial dwarfisms rather than among the isolated hypoparathyroidisms.
Downstream
Intrauterine growth retardation The prenatal arm of the growth failure.
Short stature The postnatal arm of the growth failure.
Low birth weight Prenatal growth failure measured at birth.
Small hands Acral expression of the same generalized growth deficit.
Stenosis of the medullary cavity of the long bones The radiographic finding that overlaps with Kenny-Caffey syndrome. Grouped with the skeletal arm of the growth failure; TBCE has no demonstrated role in cortical bone modelling, so the route is unestablished.
Deep-set eyes Part of the characteristic dysmorphism, grouped with the growth deficit; no craniofacial-specific mechanism is established for TBCE.
Blue sclerae Grouped with the other dysmorphic features; the scleral thinning that produces the blue appearance has no demonstrated link to the tubulin-folding defect.
Show evidence (1 reference)
PMID:19554981 SUPPORT Human Clinical
"All patients had severe intrauterine growth retardation, short stature, small hands and feet, blue sclera, deep-set eyes, microcephaly"
Growth failure with microcephaly in all patients in the series.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Sanjad-Sakati Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

16
Digestive 1
Chronic intestinal pseudo-obstruction OCCASIONAL HP:0004389 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Intestinal pseudo-obstruction (HP:0004389). HP:0004389 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:42433342 SUPPORT Human Clinical
"chronic intestinal pseudo-obstruction in 22.7%"
22.7% of the Jordanian series.
Endocrine 1
Congenital hypoparathyroidism VERY_FREQUENT HP:0008198 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Congenital hypoparathyroidism (HP:0008198). HP:0008198 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:42433342 SUPPORT Human Clinical
"All patients presented with low birth weight, dysmorphic features, hypocalcemia, congenital hypoparathyroidism, and short stature."
Universal in the Jordanian series of 22 patients.
Eye 2
Deep-set eyes VERY_FREQUENT Deeply set eye HP:0000490 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Deeply set eye (HP:0000490). HP:0000490 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19554981 SUPPORT Human Clinical
"blue sclera, deep-set eyes, microcephaly"
Present in all 21 patients.
Blue sclerae VERY_FREQUENT HP:0000592 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Blue sclerae (HP:0000592). HP:0000592 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19554981 SUPPORT Human Clinical
"small hands and feet, blue sclera, deep-set eyes"
Present in all 21 patients.
Head and Neck 1
Microcephaly VERY_FREQUENT HP:0000252 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Microcephaly (HP:0000252). HP:0000252 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19554981 SUPPORT Human Clinical
"blue sclera, deep-set eyes, microcephaly, persistent hypocalcaemia"
Microcephaly in all 21 patients.
Limbs 1
Small hands VERY_FREQUENT HP:0200055 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Small hand (HP:0200055). HP:0200055 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19554981 SUPPORT Human Clinical
"short stature, small hands and feet, blue sclera"
Present in all 21 patients.
Metabolism 1
Hypocalcemia VERY_FREQUENT HP:0002901 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypocalcemia (HP:0002901). HP:0002901 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19554981 SUPPORT Human Clinical
"All patients had severe intrauterine growth retardation, short stature, small hands and feet, blue sclera, deep-set eyes, microcephaly, persistent hypocalcaemia and hypoparathyroidism."
Persistent hypocalcemia in all 21 patients.
Nervous System 1
Intellectual disability VERY_FREQUENT HP:0001249 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Intellectual disability (HP:0001249). HP:0001249 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:42433342 SUPPORT Human Clinical
"consistently presented with congenital hypoparathyroidism, developmental delay, intellectual disability, and severe growth failure"
Consistent finding across the Jordanian cohort.
Growth 3
Intrauterine growth retardation VERY_FREQUENT HP:0001511 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Intrauterine growth retardation (HP:0001511). HP:0001511 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19554981 SUPPORT Human Clinical
"All patients had severe intrauterine growth retardation, short stature, small hands and feet, blue sclera, deep-set eyes, microcephaly"
Severe IUGR in all 21 patients.
Short stature VERY_FREQUENT HP:0004322 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short stature (HP:0004322). HP:0004322 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:42433342 SUPPORT Human Clinical
"All patients presented with low birth weight, dysmorphic features, hypocalcemia, congenital hypoparathyroidism, and short stature."
Universal in the Jordanian series.
Low birth weight VERY_FREQUENT Small for gestational age HP:0001518 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Low birth weight / small for gestational age, annotated with Small for gestational age (HP:0001518). HP:0001518 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:42433342 SUPPORT Human Clinical
"All patients presented with low birth weight, dysmorphic features"
Universal in the Jordanian series.
Other 5
Stenosis of the medullary cavity of the long bones OCCASIONAL HP:0100254 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Medullary stenosis, annotated with Stenosis of the medullary cavity of the long bones (HP:0100254). HP:0100254 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19554981 SUPPORT Human Clinical
"Medullary stenosis was detected in 2 patients."
Two of 21 patients, supporting an OCCASIONAL rather than universal frequency.
Nephrocalcinosis FREQUENT HP:0000121 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Nephrocalcinosis (HP:0000121). HP:0000121 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:42433342 SUPPORT Human Clinical
"Nephrocalcinosis occurred in 31.8% of the patients"
Quantified at 31.8% in the Jordanian series, in the FREQUENT band.
Recurrent severe infections VERY_FREQUENT Recurrent bacterial infections HP:0002718 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Recurrent bacterial infections (HP:0002718). HP:0002718 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:36258138 SUPPORT Human Clinical
"Many patients succumb in infancy to HRD due to overwhelming infections mainly caused by Pneumococcus spp."
Establishes infection as the dominant cause of early death and names the organism.
PMID:36258138 SUPPORT Human Clinical
"Three patients had bacteremia with Klebsiella, Shigella spp., and Candida. Three patients had confirmed coronavirus disease 19 (COVID-19), and two of them died from this infection."
The observed infection burden and its mortality in the studied cohort.
Impaired specific antibody response VERY_FREQUENT Decreased specific antibody response to vaccination HP:0032140 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Decreased specific antibody response to vaccination (HP:0032140). HP:0032140 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36258138 SUPPORT Human Clinical
"Patients showed high total IgA and IgE levels, low anti-pneumococcal antibodies in spite of a routine vaccination schedule, and reduced frequency of naive B cells with increased frequency of CD21lowCD27- B cells."
The humoral findings, including the failure of vaccine response that this phenotype names.
Abnormal T cell subset distribution VERY_FREQUENT Abnormal T cell physiology HP:0011840 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal T cell subset distribution, annotated with Abnormal T cell physiology (HP:0011840). HP:0011840 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36258138 SUPPORT Human Clinical
"All patients had abnormal T-cell population distributions, including reduced terminally differentiated effector memory CD8, inverted CD4/CD8 ratios, and impaired phytohemagglutinin (PHA)-induced lymphocyte proliferation."
The T-cell abnormalities in all nine patients.
🧬

Genetic Associations

1
TBCE
Gene: TBCE hgnc:11582 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is TBCE (hgnc:11582). hgnc:11582 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (2 references)
PMID:12389028 SUPPORT Human Clinical
"identification of deletion and truncation mutations of TBCE in affected individuals"
The mapping and mutation study that established TBCE as the HRD gene.
PMID:19554981 SUPPORT Human Clinical
"homozygous deletion of 12 bp (155-166del) in exon 3 of the TBCE gene"
Identifies the recurrent founder allele.
💊

Medical Actions

3
Calcium and Vitamin D Replacement
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Chronic treatment of hypoparathyroid hypocalcemia. The Jordanian series is explicit that this therapy carries its own burden - nephrocalcinosis and other complications of chronic calcium therapy are among the comorbidities associated with increased mortality - so monitoring for hypercalciuria and renal calcification is part of the treatment, not an optional extra.
Target Phenotypes: Hypocalcemia HP:0002901 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Hypocalcemia (HP:0002901). HP:0002901 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:42433342 SUPPORT Human Clinical
"dental anomalies, intestinal pseudo-obstruction, and complications from chronic calcium therapy"
Identifies complications of chronic calcium therapy as a recognized comorbidity, which is what makes monitoring part of the treatment.
Infection Surveillance and Supportive Care
Action: Supportive CareNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. NCIT:C15747
Nearly half the Jordanian cohort died, most often of pneumonia and sepsis, so aggressive management of intercurrent infection is the intervention with the clearest bearing on survival.
Show evidence (1 reference)
PMID:42433342 SUPPORT Human Clinical
"Ten patients (45.5%) died, most commonly due to pneumonia and sepsis."
Establishes infection as the dominant cause of death, and so the priority for supportive care.
Genetic Counseling
Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Autosomal recessive counseling, with carrier testing informative in populations carrying the c.155-166del founder allele.
Show evidence (1 reference)
PMID:19554981 SUPPORT Human Clinical
"All of the parents were heterozygous carriers of this mutation."
Obligate carrier parents with a single recurrent allele make carrier testing straightforward in these populations.
🔬

Diagnosis

3
Molecular genetic testing of TBCE (Biallelic TBCE pathogenic variants; in Middle Eastern and North African patients almost always the homozygous founder deletion)
Nearly all affected people of Arab descent in the Middle East are homozygous for the same 12-base-pair deletion in the second coding exon of TBCE and share an ancestral haplotype, so a targeted founder-allele test is the efficient first-line study in that population. The same founder allele is found in patients labelled Kenny-Caffey type 1 - the two diagnoses are allelic, and the molecular result does not distinguish them.
molecular genetic testing NCIT:C15709 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:12389028 SUPPORT Human Clinical
"Both traits have previously been mapped to chromosome 1q43-44 (refs 5,6) and, despite the observed clinical variability, share an ancestral haplotype, suggesting a common founder mutation."
The shared ancestral haplotype across both diagnoses, which is what makes a targeted founder test appropriate and what limits its ability to distinguish the two labels.
Serum calcium, phosphate and parathyroid hormone (Hypocalcemia with inappropriately low or undetectable PTH)
Usually the presenting abnormality, since neonatal hypocalcemic seizures or tetany are how these infants come to attention. Combined with the growth and dysmorphic features it is enough for a clinical diagnosis where sequencing is not available - five of the Jordanian series were diagnosed on phenotype and family history alone.
serum biochemistry NCIT:C25294 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:42433342 SUPPORT Human Clinical
"The diagnosis of SSS is established through a combination of medical history (family history of SSS, gestational age, and birth weight), clinical features (dysmorphic features such as deep-set small eyes, micrognathia, narrow face, large floppy ears, and short stature), laboratory findings..."
Sets out the four diagnostic strands, of which this record covers the laboratory one.
Clinical scoring against major and minor criteria (Growth failure, characteristic dysmorphism and hypoparathyroidism scored against published major/minor criteria)
There is no GeneReviews chapter for this disorder; the nearest thing to a consensus definition is a criteria set proposed from a Tunisian series and literature review, explicitly intended to decide who should be sent for molecular testing rather than to replace it.
clinical evaluation NCIT:C124351 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:30638765 SUPPORT Human Clinical
"Reviewing the literature on both its clinical and biochemical characteristics, we suggest for the first time, based on defined major and minor SSS criteria, a clinical scoring system for the diagnosis of SSS."
The proposed scoring system this record describes.
📊

Prevalence

2
Kuwait
Cases In Literature Unknown
21 patients from 16 families in a single national series. Parental consanguinity was recorded in only 12.5% of families, which the authors read as evidence of a high heterozygous carrier rate rather than of consanguinity-driven ascertainment.
Show evidence (1 reference)
PMID:19554981 SUPPORT Human Clinical
"We studied 21 patients with Sanjad-Sakati syndrome (SSS) from 16 families."
Gives the case count for the Kuwaiti series.
Middle East
Unknown Rare
Reported almost exclusively in Middle Eastern populations; no population rate has been published.
Show evidence (1 reference)
PMID:12389028 SUPPORT Human Clinical
"is an autosomal recessive disorder reported almost exclusively in Middle Eastern populations"
States the geographic restriction that stands in for a prevalence figure.
🐁

Animal Models

1
pmn/pmn mouse (Tbce p.Trp524Gly)
The only established Tbce animal model, and it is a spontaneous mouse mutant that was studied as a motor neuron disease model for a decade before the human gene was identified. It carries a substitution at the terminal residue of Tbce that destabilizes the protein - mechanistically the same class of lesion as the human disease - and it reproduces the microtubule deficit faithfully. It does not reproduce the human syndrome: pmn mice develop progressive motor axon degeneration and die at four to six weeks, while human HRD patients have hypoparathyroidism, primordial growth failure and immunodeficiency without a motor neuronopathy. The model is therefore informative about what TBCE does to microtubules and uninformative about why the human parathyroid fails.
Species
Mouse
Genotype
Tbce c.1570T>G p.(Trp524Gly), homozygous (progressive motor neuronopathy allele)
Publication
PMID:12389029
Pathograph links
Loss of Tubulin-Folding Cofactor E recapitulates fidelity: high A destabilizing missense allele reducing Tbce protein, complemented by a wild-type transgene - the causal relationship is established rather than correlative.
Limitations: A single missense allele at the extreme C-terminus, not the human 12-base-pair deletion, and studied in a species where the resulting phenotype is a motor neuronopathy.
Readouts
Rescue of phenotype by wild-type Tbce transgene
Direction: RESTORED
Interpretation: Transgenic complementation restoring a normal phenotype establishes that Tbce loss is the cause rather than a linked marker.
Show evidence (1 reference)
PMID:12389029 SUPPORT Model Organism
"Transgenic complementation with a wildtype Tbce cDNA restored a normal phenotype in mutant mice."
Establishes causality by rescue.
Show evidence (1 reference)
PMID:12389029 SUPPORT Model Organism
"we identify the pmn mutation as resulting in a Trp524Gly substitution at the last residue of the tubulin-specific chaperone e (Tbce) protein that leads to decreased protein stability"
Identifies the model's lesion as a destabilizing Tbce allele, the same class of defect as the human disease.
Reduced Microtubule Density and Perturbed Polarity recapitulates fidelity: moderate Microtubule loss is demonstrated directly in mutant nerve, and the later study localizes TBCE to the Golgi and shows that microtubule loss proceeds retrogradely in step with axonal dying back - a cell-biological account of the cytoskeletal defect that the human patient-cell data can only measure statically.
Limitations: Measured in motor axons, a compartment not implicated in the human disease; whether parathyroid or lymphoid cells show the same defect in vivo is untested.
Readouts
Axonal microtubule number in sciatic and phrenic nerve
Direction: DECREASED
Interpretation: Direct structural confirmation that Tbce loss depletes microtubules in vivo.
Show evidence (1 reference)
PMID:12389029 SUPPORT Model Organism
"Electron microscopy of the sciatic and phrenic nerves of affected mice showed a reduced number of microtubules, probably due to defective stabilization."
The structural measurement behind this readout.
Show evidence (1 reference)
PMID:17699660 SUPPORT Model Organism
"In pmn mice, TBCE is destabilized and disappears from the Golgi apparatus of motor neurons, and microtubules are lost in distal axons."
Connects the destabilized protein, its subcellular site of action, and the microtubule loss in the same model.
Disturbed Microtubule-Dependent Membrane Trafficking partially recapitulates fidelity: moderate The model supplies the mechanistic content this node otherwise lacks: TBCE is a peripheral membrane protein at the Golgi, and disrupting the Golgi pharmacologically phenocopies the mutation's effect on tubulin routing. That makes a Golgi-centred trafficking defect a demonstrated mechanism in neurons rather than only a proposal.
Limitations: Shown for tubulin routing in motor neurons. The human node concerns secretory trafficking in parathyroid cells, which this model does not address at all - the parathyroid phenotype is absent in pmn mice.
Readouts
Axonal tubulin routing from the Golgi apparatus
Direction: DECREASED
Interpretation: Three independent perturbations converging on the same defect place TBCE in a Golgi-dependent tubulin-routing pathway.
Show evidence (1 reference)
PMID:17699660 SUPPORT Model Organism
"In cultured motor neurons, the pmn mutation, interference RNA-mediated TBCE depletion, and brefeldin A-mediated Golgi disruption all compromise axonal tubulin routing."
The convergent evidence behind this readout.
Show evidence (1 reference)
PMID:17699660 SUPPORT Model Organism
"We demonstrate that TBCE is a peripheral membrane-associated protein that accumulates at the Golgi apparatus."
Localizes TBCE to the compartment this node concerns, which is what makes the model partially informative for it.
Parathyroid Failure and Congenital Hypoparathyroidism fails to recapitulate fidelity: low pmn mice have no reported hypoparathyroidism. The defining endocrine feature of the human disease is absent from the only Tbce model, so the step from a general cytoskeletal defect to selective parathyroid aplasia has no animal support.
Limitations: The mouse phenotype is a progressive motor neuronopathy with death at four to six weeks - a lethal course in a compartment the human disease spares, and possibly too early for a parathyroid phenotype to be ascertained. The published characterizations do not report parathyroid assessment either way, so this is an absence of evidence in a model whose overall phenotype is clearly divergent, not a documented negative parathyroid study.
Show evidence (1 reference)
PMID:12389029 SUPPORT Model Organism
"Mice that are homozygous with respect to the progressive motor neuronopathy (pmn) mutation (chromosome 13) develop a progressive caudio-cranial degeneration of their motor axons from the age of two weeks and die four to six weeks after birth."
The full reported phenotype of the model is a motor neuronopathy; no endocrine feature is described, which is the divergence this link records.
{ }

Source YAML

click to show 
name: Sanjad-Sakati Syndrome
creation_date: "2026-08-27T01:40:00Z"
category: Mendelian
synonyms:
- SSS
- hypoparathyroidism-retardation-dysmorphism syndrome
- HRD syndrome
- HRD
- Richardson-Kirk syndrome
- Kenny-Caffey syndrome type 1
description: >-
  Sanjad-Sakati syndrome (HRD) is an autosomal recessive disorder of congenital
  hypoparathyroidism, severe pre- and postnatal growth failure, microcephaly,
  characteristic dysmorphism and intellectual disability, reported almost
  exclusively in populations of the Arabian peninsula and the wider Middle East,
  where a founder 12-bp deletion in TBCE accounts for most cases. TBCE encodes
  one of the chaperones that fold alpha-tubulin and build alpha-beta tubulin
  heterodimers, so this is a chaperone disease of the tubulin assembly pathway
  rather than a primary parathyroid gene defect - the parathyroid link runs
  through microtubule-dependent secretory traffic. The same gene, at the more
  severe end of its allelic spectrum, causes autosomal recessive Kenny-Caffey
  syndrome, which adds osteosclerosis and recurrent bacterial infection; the two
  share an ancestral haplotype. Neonatal presentation is usually hypocalcemic
  seizures or apnea, and mortality is high, driven by pneumonia and sepsis.
disease_term:
  preferred_term: hypoparathyroidism-retardation-dysmorphism syndrome
  term:
    id: MONDO:0009426
    label: hypoparathyroidism-retardation-dysmorphism syndrome
parents:
- Autosomal recessive disease
- Primordial dwarfism
classifications:
  harrisons_chapter:
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
  - classification_value: ENDOCRINOLOGY_METABOLISM
  isds_skeletal_category:
  - classification_value: primordial_dwarfism_and_slender_bones
    notes: >-
      ISDS Nosology of Genetic Skeletal Disorders, 2023 revision (Unger et al.,
      PMID:36779427), group 21 "Primordial dwarfism and slender bone
      dysplasias", NOS 21-0040 "Sanjad-Sakati syndrome, recessive, TBCE-related"
      (OMIM 241410). The nosology lists exactly one TBCE row, so the assignment
      is 1:1 with this entry. Autosomal recessive Kenny-Caffey syndrome, the
      allelic osteosclerotic disorder at the severe end of the same TBCE
      spectrum, is not separately listed; the dominant FAM111A Kenny-Caffey
      syndrome is a different gene and a different row (NOS 21-0050).
prevalence:
- population: Kuwait
  measure_type: CASES_IN_LITERATURE
  prevalence_class: UNKNOWN
  notes: >-
    21 patients from 16 families in a single national series. Parental
    consanguinity was recorded in only 12.5% of families, which the authors read
    as evidence of a high heterozygous carrier rate rather than of
    consanguinity-driven ascertainment.
  evidence:
  - reference: PMID:19554981
    reference_title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We studied 21 patients with Sanjad-Sakati syndrome (SSS) from 16 families."
    explanation: >-
      Gives the case count for the Kuwaiti series.
- population: Middle East
  measure_type: UNKNOWN
  prevalence_class: RARE
  notes: >-
    Reported almost exclusively in Middle Eastern populations; no population
    rate has been published.
  evidence:
  - reference: PMID:12389028
    reference_title: "Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "is an autosomal recessive disorder reported almost exclusively in Middle Eastern populations"
    explanation: >-
      States the geographic restriction that stands in for a prevalence figure.
inheritance:
- name: Autosomal recessive
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    Biallelic TBCE variants. In the Kuwaiti series every affected individual was
    homozygous for the 12-bp founder deletion and every parent was a
    heterozygous carrier.
  evidence:
  - reference: PMID:19554981
    reference_title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected persons had homozygous deletion of 12 bp (155-166del) in exon 3 of the TBCE gene. All of the parents were heterozygous carriers of this mutation."
    explanation: >-
      Homozygosity in all affected individuals with obligate carrier parents is
      the classic autosomal recessive segregation pattern.
genetic:
- name: TBCE
  gene_term:
    preferred_term: TBCE
    term:
      id: hgnc:11582
      label: TBCE
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  notes: >-
    TBCE (1q42-43) encodes tubulin-folding cofactor E. Deletion and truncation
    variants cause disease; c.155-166del (a 12-bp exon 3 deletion) is the
    founder allele across the Arabian peninsula and has also been found on a
    Moroccan background. TBCE is allelic for autosomal recessive Kenny-Caffey
    syndrome and, through a separate variant class, for an early-onset
    progressive encephalopathy with distal spinal muscular atrophy - so a TBCE
    variant does not by itself specify this entity.
  evidence:
  - reference: PMID:12389028
    reference_title: "Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "identification of deletion and truncation mutations of TBCE in affected individuals"
    explanation: >-
      The mapping and mutation study that established TBCE as the HRD gene.
  - reference: PMID:19554981
    reference_title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "homozygous deletion of 12 bp (155-166del) in exon 3 of the TBCE gene"
    explanation: >-
      Identifies the recurrent founder allele.
pathophysiology:
- name: Loss of Tubulin-Folding Cofactor E
  biological_scale: MOLECULAR
  role: trigger
  description: >-
    Biallelic deletion or truncation of TBCE removes one of the chaperones
    required to fold alpha-tubulin subunits and assemble them into alpha-beta
    tubulin heterodimers. The primary lesion is therefore in the tubulin supply
    chain, not in any parathyroid-specific pathway - which is what makes this a
    chaperone disease.
  genes:
  - preferred_term: TBCE
    term:
      id: hgnc:11582
      label: TBCE
  biological_processes:
  - preferred_term: tubulin complex assembly
    term:
      id: GO:0007021
      label: tubulin complex assembly
    modifier: DECREASED
  - preferred_term: protein folding
    term:
      id: GO:0006457
      label: protein folding
    modifier: DECREASED
  downstream:
  - target: Reduced Microtubule Density and Perturbed Polarity
  evidence:
  - reference: PMID:12389028
    reference_title: "Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The gene TBCE encodes one of several chaperone proteins required for the proper folding of alpha-tubulin subunits and the formation of alpha-beta-tubulin heterodimers."
    explanation: >-
      States the molecular function whose loss initiates the disease.
- name: Reduced Microtubule Density and Perturbed Polarity
  biological_scale: CELLULAR
  description: >-
    Patient fibroblasts and lymphoblastoid cells show lower microtubule density
    at the microtubule-organizing centre and disturbed microtubule polarity -
    the direct cellular readout of an inadequate supply of folded tubulin
    heterodimers.
  cell_types:
  - preferred_term: dermal fibroblast
    term:
      id: CL:0000057
      label: fibroblast
  biological_processes:
  - preferred_term: microtubule cytoskeleton organization
    term:
      id: GO:0000226
      label: microtubule cytoskeleton organization
    modifier: DECREASED
  downstream:
  - target: Disturbed Microtubule-Dependent Membrane Trafficking
  - target: Microcephaly
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Microtubule-dependent neural progenitor division is the plausible route
      to reduced brain growth; the specific requirement in neural progenitors
      has not been demonstrated for TBCE.
  - target: Intellectual disability
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Grouped with the microcephaly as a neurodevelopmental consequence of the
      cytoskeletal defect; the route is not established.
  - target: Combined Immunodeficiency
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Lymphocyte activation and division are microtubule-dependent, and the
      same lymphoblastoid cells that carry the measured microtubule defect are
      the ones that proliferate poorly - but no study has shown the
      immunological deficit to follow from the cytoskeletal one in this
      disorder, so the edge is drawn as an inference.
  evidence:
  - reference: PMID:12389028
    reference_title: "Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Analysis of diseased fibroblasts and lymphoblastoid cells showed lower microtubule density at the microtubule-organizing center (MTOC) and perturbed microtubule polarity in diseased cells."
    explanation: >-
      The measured cytoskeletal defect in patient cells.
- name: Disturbed Microtubule-Dependent Membrane Trafficking
  biological_scale: CELLULAR
  description: >-
    Organelles that depend on microtubules for membrane trafficking - the Golgi
    and the late endosomal compartment - are structurally disturbed in patient
    cells. This is the step that plausibly connects a general cytoskeletal
    defect to a secretory endocrine organ, and the authors propose it as a link
    between tubulin physiology and parathyroid development. It remains a
    proposal: no study has shown parathyroid-specific trafficking failure
    directly.
  biological_processes:
  - preferred_term: Golgi organization
    term:
      id: GO:0007030
      label: Golgi organization
    modifier: ABNORMAL
  cellular_components:
  - preferred_term: Golgi apparatus
    term:
      id: GO:0005794
      label: Golgi apparatus
  downstream:
  - target: Parathyroid Failure and Congenital Hypoparathyroidism
  - target: Severe Pre- and Postnatal Growth Failure
  - target: Chronic intestinal pseudo-obstruction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Enteric neuromuscular function depends on microtubule-based transport;
      grouped here as the most plausible route, though it has not been shown
      directly in this disorder.
  evidence:
  - reference: PMID:12389028
    reference_title: "Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Immunofluorescence and ultrastructural studies showed disturbances in subcellular organelles that require microtubules for membrane trafficking, such as the Golgi and late endosomal compartments."
    explanation: >-
      Documents the trafficking-organelle disturbance downstream of the
      microtubule defect.
  - reference: PMID:12389028
    reference_title: "Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "establish a potential connection between tubulin physiology and the development of the parathyroid"
    explanation: >-
      The parathyroid link is offered as a potential connection, not a
      demonstrated one - hence PARTIAL, and hence the hedge in this node's
      description.
- name: Parathyroid Failure and Congenital Hypoparathyroidism
  biological_scale: ORGANISM
  role: consequence
  description: >-
    Congenital hypoparathyroidism with persistent hypocalcemia, present in every
    reported patient and typically declaring itself in the neonatal period as a
    hypocalcemic seizure or apnea. Chronic calcium and vitamin D therapy is
    itself a source of morbidity through nephrocalcinosis.
  cell_types:
  - preferred_term: parathyroid chief cell
    term:
      id: CL:0000446
      label: chief cell of parathyroid gland
  locations:
  - preferred_term: parathyroid gland
    term:
      id: UBERON:0001132
      label: parathyroid gland
  downstream:
  - target: Congenital hypoparathyroidism
    description: >-
      The endocrine endpoint of parathyroid failure.
  - target: Hypocalcemia
    description: >-
      PTH deficiency is the direct cause of the hypocalcemia.
  - target: Nephrocalcinosis
    description: >-
      Largely iatrogenic: a consequence of the chronic calcium and vitamin D
      therapy that the hypoparathyroidism requires, rather than of the primary
      lesion.
  evidence:
  - reference: PMID:19554981
    reference_title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients had severe intrauterine growth retardation, short stature, small hands and feet, blue sclera, deep-set eyes, microcephaly, persistent hypocalcaemia and hypoparathyroidism."
    explanation: >-
      Present in all 21 patients in the Kuwaiti series.
- name: Combined Immunodeficiency
  biological_scale: ORGANISM
  role: consequence
  description: >-
    HRD is not a syndromic disease that happens to get infections - the immune
    defect is itself part of the disorder, and it is the main cause of death.
    A dedicated immunological workup of nine patients found abnormalities in
    both arms: a humoral defect (high total IgA and IgE but poor
    anti-pneumococcal titres despite routine vaccination, fewer naive B cells,
    expanded CD21-low CD27-negative B cells) and a cellular defect (inverted
    CD4/CD8 ratios, reduced terminally differentiated effector memory CD8 cells,
    and impaired PHA-induced proliferation in every patient). Neutrophil
    superoxide production and chemotaxis were normal, which locates the deficit
    in lymphocytes rather than in innate effector function.
  cell_types:
  - preferred_term: T cell
    term:
      id: CL:0000084
      label: T cell
  - preferred_term: B cell
    term:
      id: CL:0000236
      label: B cell
  biological_processes:
  - preferred_term: lymphocyte proliferation
    term:
      id: GO:0046651
      label: lymphocyte proliferation
    modifier: DECREASED
  - preferred_term: humoral immune response
    term:
      id: GO:0006959
      label: humoral immune response
    modifier: ABNORMAL
  downstream:
  - target: Recurrent severe infections
    description: >-
      The clinical expression of the combined deficit, and the leading cause of
      death in infancy.
  - target: Impaired specific antibody response
    description: >-
      The measured humoral component - vaccination does not produce protective
      anti-pneumococcal titres.
  - target: Abnormal T cell subset distribution
    description: >-
      The measured cellular component.
  evidence:
  - reference: PMID:36258138
    reference_title: "Hypoparathyroidism-Retardation-Dysmorphism Syndrome due to a Variant in the Tubulin-Specific Chaperone E Gene as a Cause of Combined Immune Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "HRD is a combined immunodeficiency disease with syndromic features, manifesting in severe invasive bacterial and viral infections."
    explanation: >-
      States the conclusion this node asserts - that the immunodeficiency is a
      defining component of the disorder rather than a complication of it.
  - reference: PMID:36258138
    reference_title: "Hypoparathyroidism-Retardation-Dysmorphism Syndrome due to a Variant in the Tubulin-Specific Chaperone E Gene as a Cause of Combined Immune Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients had abnormal T-cell population distributions, including reduced terminally differentiated effector memory CD8, inverted CD4/CD8 ratios, and impaired phytohemagglutinin (PHA)-induced lymphocyte proliferation."
    explanation: >-
      The cellular arm, in all nine patients studied.
  - reference: PMID:36258138
    reference_title: "Hypoparathyroidism-Retardation-Dysmorphism Syndrome due to a Variant in the Tubulin-Specific Chaperone E Gene as a Cause of Combined Immune Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Neutrophil superoxide production and chemotaxis were normal in all patients tested."
    explanation: >-
      A negative result that localizes the defect to lymphocytes and excludes a
      neutrophil functional disorder.
- name: Severe Pre- and Postnatal Growth Failure
  biological_scale: ORGANISM
  role: consequence
  description: >-
    Extreme growth failure beginning in utero, with microcephaly and the
    characteristic dysmorphism, and without catch-up - the feature that places
    this disorder among the primordial dwarfisms rather than among the isolated
    hypoparathyroidisms.
  downstream:
  - target: Intrauterine growth retardation
    description: >-
      The prenatal arm of the growth failure.
  - target: Short stature
    description: >-
      The postnatal arm of the growth failure.
  - target: Low birth weight
    description: >-
      Prenatal growth failure measured at birth.
  - target: Small hands
    description: >-
      Acral expression of the same generalized growth deficit.
  - target: Stenosis of the medullary cavity of the long bones
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The radiographic finding that overlaps with Kenny-Caffey syndrome.
      Grouped with the skeletal arm of the growth failure; TBCE has no
      demonstrated role in cortical bone modelling, so the route is
      unestablished.
  - target: Deep-set eyes
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Part of the characteristic dysmorphism, grouped with the growth deficit;
      no craniofacial-specific mechanism is established for TBCE.
  - target: Blue sclerae
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Grouped with the other dysmorphic features; the scleral thinning that
      produces the blue appearance has no demonstrated link to the
      tubulin-folding defect.
  evidence:
  - reference: PMID:19554981
    reference_title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients had severe intrauterine growth retardation, short stature, small hands and feet, blue sclera, deep-set eyes, microcephaly"
    explanation: >-
      Growth failure with microcephaly in all patients in the series.
phenotypes:
- category: Endocrine
  name: Congenital hypoparathyroidism
  phenotype_term:
    preferred_term: Congenital hypoparathyroidism
    term:
      id: HP:0008198
      label: Congenital hypoparathyroidism
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:42433342
    reference_title: "Sanjad-Sakati Syndrome in Jordan: Clinical Features, Comorbidities, and Mortality Rate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients presented with low birth weight, dysmorphic features, hypocalcemia, congenital hypoparathyroidism, and short stature."
    explanation: >-
      Universal in the Jordanian series of 22 patients.
- category: Metabolic
  name: Hypocalcemia
  phenotype_term:
    preferred_term: Hypocalcemia
    term:
      id: HP:0002901
      label: Hypocalcemia
  frequency: VERY_FREQUENT
  description: >-
    Usually the presenting problem, as a neonatal seizure or apnea.
  evidence:
  - reference: PMID:19554981
    reference_title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients had severe intrauterine growth retardation, short stature, small hands and feet, blue sclera, deep-set eyes, microcephaly, persistent hypocalcaemia and hypoparathyroidism."
    explanation: >-
      Persistent hypocalcemia in all 21 patients.
- category: Growth
  name: Intrauterine growth retardation
  phenotype_term:
    preferred_term: Intrauterine growth retardation
    term:
      id: HP:0001511
      label: Intrauterine growth retardation
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:19554981
    reference_title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients had severe intrauterine growth retardation, short stature, small hands and feet, blue sclera, deep-set eyes, microcephaly"
    explanation: >-
      Severe IUGR in all 21 patients.
- category: Growth
  name: Short stature
  phenotype_term:
    preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:42433342
    reference_title: "Sanjad-Sakati Syndrome in Jordan: Clinical Features, Comorbidities, and Mortality Rate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients presented with low birth weight, dysmorphic features, hypocalcemia, congenital hypoparathyroidism, and short stature."
    explanation: >-
      Universal in the Jordanian series.
- category: Growth
  name: Low birth weight
  phenotype_term:
    preferred_term: Low birth weight / small for gestational age
    term:
      id: HP:0001518
      label: Small for gestational age
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:42433342
    reference_title: "Sanjad-Sakati Syndrome in Jordan: Clinical Features, Comorbidities, and Mortality Rate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients presented with low birth weight, dysmorphic features"
    explanation: >-
      Universal in the Jordanian series.
- category: Neurological
  name: Microcephaly
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:19554981
    reference_title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "blue sclera, deep-set eyes, microcephaly, persistent hypocalcaemia"
    explanation: >-
      Microcephaly in all 21 patients.
- category: Neurological
  name: Intellectual disability
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  frequency: VERY_FREQUENT
  description: >-
    The "R" of HRD. This is the point of contrast with 3-M syndrome and
    Saul-Wilson syndrome, in which cognition is spared.
  evidence:
  - reference: PMID:42433342
    reference_title: "Sanjad-Sakati Syndrome in Jordan: Clinical Features, Comorbidities, and Mortality Rate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "consistently presented with congenital hypoparathyroidism, developmental delay, intellectual disability, and severe growth failure"
    explanation: >-
      Consistent finding across the Jordanian cohort.
- category: Craniofacial
  name: Deep-set eyes
  phenotype_term:
    preferred_term: Deeply set eye
    term:
      id: HP:0000490
      label: Deeply set eye
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:19554981
    reference_title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "blue sclera, deep-set eyes, microcephaly"
    explanation: >-
      Present in all 21 patients.
- category: Ocular
  name: Blue sclerae
  phenotype_term:
    preferred_term: Blue sclerae
    term:
      id: HP:0000592
      label: Blue sclerae
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:19554981
    reference_title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "small hands and feet, blue sclera, deep-set eyes"
    explanation: >-
      Present in all 21 patients.
- category: Skeletal
  name: Small hands
  phenotype_term:
    preferred_term: Small hand
    term:
      id: HP:0200055
      label: Small hand
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:19554981
    reference_title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "short stature, small hands and feet, blue sclera"
    explanation: >-
      Present in all 21 patients.
- category: Skeletal
  name: Stenosis of the medullary cavity of the long bones
  phenotype_term:
    preferred_term: Medullary stenosis
    term:
      id: HP:0100254
      label: Stenosis of the medullary cavity of the long bones
  frequency: OCCASIONAL
  description: >-
    The radiographic finding that overlaps with Kenny-Caffey syndrome; detected
    in a minority of patients here rather than being a defining feature.
  evidence:
  - reference: PMID:19554981
    reference_title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Medullary stenosis was detected in 2 patients."
    explanation: >-
      Two of 21 patients, supporting an OCCASIONAL rather than universal
      frequency.
- category: Renal
  name: Nephrocalcinosis
  phenotype_term:
    preferred_term: Nephrocalcinosis
    term:
      id: HP:0000121
      label: Nephrocalcinosis
  frequency: FREQUENT
  description: >-
    Largely a complication of long-term calcium and vitamin D replacement rather
    than of the primary lesion, which is why the Jordanian series frames it as a
    comorbidity of chronic therapy.
  evidence:
  - reference: PMID:42433342
    reference_title: "Sanjad-Sakati Syndrome in Jordan: Clinical Features, Comorbidities, and Mortality Rate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nephrocalcinosis occurred in 31.8% of the patients"
    explanation: >-
      Quantified at 31.8% in the Jordanian series, in the FREQUENT band.
- category: Gastrointestinal
  name: Chronic intestinal pseudo-obstruction
  phenotype_term:
    preferred_term: Intestinal pseudo-obstruction
    term:
      id: HP:0004389
      label: Intestinal pseudo-obstruction
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:42433342
    reference_title: "Sanjad-Sakati Syndrome in Jordan: Clinical Features, Comorbidities, and Mortality Rate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "chronic intestinal pseudo-obstruction in 22.7%"
    explanation: >-
      22.7% of the Jordanian series.
- category: Immunological
  name: Recurrent severe infections
  phenotype_term:
    preferred_term: Recurrent bacterial infections
    term:
      id: HP:0002718
      label: Recurrent bacterial infections
  frequency: VERY_FREQUENT
  diagnostic: false
  description: >-
    Invasive bacterial and viral infection is the principal cause of death.
    Pneumococcal disease dominates historically, which is why antibiotic
    prophylaxis became routine in the Soroka cohort; in that cohort under
    prophylaxis the observed episodes were Klebsiella, Shigella and Candida
    bacteraemia, and two of three COVID-19 infections were fatal.
  evidence:
  - reference: PMID:36258138
    reference_title: "Hypoparathyroidism-Retardation-Dysmorphism Syndrome due to a Variant in the Tubulin-Specific Chaperone E Gene as a Cause of Combined Immune Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Many patients succumb in infancy to HRD due to overwhelming infections mainly caused by Pneumococcus spp."
    explanation: >-
      Establishes infection as the dominant cause of early death and names the
      organism.
  - reference: PMID:36258138
    reference_title: "Hypoparathyroidism-Retardation-Dysmorphism Syndrome due to a Variant in the Tubulin-Specific Chaperone E Gene as a Cause of Combined Immune Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Three patients had bacteremia with Klebsiella, Shigella spp., and Candida. Three patients had confirmed coronavirus disease 19 (COVID-19), and two of them died from this infection."
    explanation: >-
      The observed infection burden and its mortality in the studied cohort.
- category: Immunological
  name: Impaired specific antibody response
  phenotype_term:
    preferred_term: Decreased specific antibody response to vaccination
    term:
      id: HP:0032140
      label: Decreased specific antibody response to vaccination
  frequency: VERY_FREQUENT
  description: >-
    A dissociated humoral picture: total IgA and IgE are high, but protective
    antibody is not made. Anti-pneumococcal titres remain low despite a
    completed routine vaccination schedule, and the B-cell compartment shows
    fewer naive cells with an expanded CD21-low CD27-negative population.
  evidence:
  - reference: PMID:36258138
    reference_title: "Hypoparathyroidism-Retardation-Dysmorphism Syndrome due to a Variant in the Tubulin-Specific Chaperone E Gene as a Cause of Combined Immune Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patients showed high total IgA and IgE levels, low anti-pneumococcal antibodies in spite of a routine vaccination schedule, and reduced frequency of naive B cells with increased frequency of CD21lowCD27- B cells."
    explanation: >-
      The humoral findings, including the failure of vaccine response that this
      phenotype names.
- category: Immunological
  name: Abnormal T cell subset distribution
  phenotype_term:
    preferred_term: Abnormal T cell subset distribution
    term:
      id: HP:0011840
      label: Abnormal T cell physiology
  frequency: VERY_FREQUENT
  description: >-
    Present in every patient studied: inverted CD4/CD8 ratio, reduced
    terminally differentiated effector memory CD8 cells, and impaired
    proliferation to PHA.
  evidence:
  - reference: PMID:36258138
    reference_title: "Hypoparathyroidism-Retardation-Dysmorphism Syndrome due to a Variant in the Tubulin-Specific Chaperone E Gene as a Cause of Combined Immune Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients had abnormal T-cell population distributions, including reduced terminally differentiated effector memory CD8, inverted CD4/CD8 ratios, and impaired phytohemagglutinin (PHA)-induced lymphocyte proliferation."
    explanation: >-
      The T-cell abnormalities in all nine patients.
diagnosis:
- name: Molecular genetic testing of TBCE
  diagnosis_term:
    preferred_term: molecular genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  presence: Biallelic TBCE pathogenic variants; in Middle Eastern and North African patients almost always the homozygous founder deletion
  description: >-
    Nearly all affected people of Arab descent in the Middle East are
    homozygous for the same 12-base-pair deletion in the second coding exon of
    TBCE and share an ancestral haplotype, so a targeted founder-allele test is
    the efficient first-line study in that population. The same founder allele
    is found in patients labelled Kenny-Caffey type 1 - the two diagnoses are
    allelic, and the molecular result does not distinguish them.
  evidence:
  - reference: PMID:12389028
    reference_title: "Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Both traits have previously been mapped to chromosome 1q43-44 (refs 5,6) and, despite the observed clinical variability, share an ancestral haplotype, suggesting a common founder mutation."
    explanation: >-
      The shared ancestral haplotype across both diagnoses, which is what makes
      a targeted founder test appropriate and what limits its ability to
      distinguish the two labels.
- name: Serum calcium, phosphate and parathyroid hormone
  diagnosis_term:
    preferred_term: serum biochemistry
    term:
      id: NCIT:C25294
      label: Laboratory Procedure
  presence: Hypocalcemia with inappropriately low or undetectable PTH
  description: >-
    Usually the presenting abnormality, since neonatal hypocalcemic seizures or
    tetany are how these infants come to attention. Combined with the growth
    and dysmorphic features it is enough for a clinical diagnosis where
    sequencing is not available - five of the Jordanian series were diagnosed
    on phenotype and family history alone.
  evidence:
  - reference: PMID:42433342
    reference_title: "Sanjad-Sakati Syndrome in Jordan: Clinical Features, Comorbidities, and Mortality Rate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnosis of SSS is established through a combination of medical history (family history of SSS, gestational age, and birth weight), clinical features (dysmorphic features such as deep-set small eyes, micrognathia, narrow face, large floppy ears, and short stature), laboratory findings (hypoparathyroidism, hypocalcemia), and genetic studies (mutations in the TBCE gene on chromosome 1q42-43)."
    explanation: >-
      Sets out the four diagnostic strands, of which this record covers the
      laboratory one.
- name: Clinical scoring against major and minor criteria
  diagnosis_term:
    preferred_term: clinical evaluation
    term:
      id: NCIT:C124351
      label: Clinical Evaluation
  presence: Growth failure, characteristic dysmorphism and hypoparathyroidism scored against published major/minor criteria
  description: >-
    There is no GeneReviews chapter for this disorder; the nearest thing to a
    consensus definition is a criteria set proposed from a Tunisian series and
    literature review, explicitly intended to decide who should be sent for
    molecular testing rather than to replace it.
  evidence:
  - reference: PMID:30638765
    reference_title: "Additional Tunisian patients with Sanjad-Sakati syndrome: A review toward a consensus on diagnostic criteria."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Reviewing the literature on both its clinical and biochemical characteristics, we suggest for the first time, based on defined major and minor SSS criteria, a clinical scoring system for the diagnosis of SSS."
    explanation: >-
      The proposed scoring system this record describes.
treatments:
- name: Calcium and Vitamin D Replacement
  description: >-
    Chronic treatment of hypoparathyroid hypocalcemia. The Jordanian series is
    explicit that this therapy carries its own burden - nephrocalcinosis and
    other complications of chronic calcium therapy are among the comorbidities
    associated with increased mortality - so monitoring for hypercalciuria and
    renal calcification is part of the treatment, not an optional extra.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_phenotypes:
  - preferred_term: Hypocalcemia
    term:
      id: HP:0002901
      label: Hypocalcemia
  evidence:
  - reference: PMID:42433342
    reference_title: "Sanjad-Sakati Syndrome in Jordan: Clinical Features, Comorbidities, and Mortality Rate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "dental anomalies, intestinal pseudo-obstruction, and complications from chronic calcium therapy"
    explanation: >-
      Identifies complications of chronic calcium therapy as a recognized
      comorbidity, which is what makes monitoring part of the treatment.
- name: Infection Surveillance and Supportive Care
  description: >-
    Nearly half the Jordanian cohort died, most often of pneumonia and sepsis,
    so aggressive management of intercurrent infection is the intervention with
    the clearest bearing on survival.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:42433342
    reference_title: "Sanjad-Sakati Syndrome in Jordan: Clinical Features, Comorbidities, and Mortality Rate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Ten patients (45.5%) died, most commonly due to pneumonia and sepsis."
    explanation: >-
      Establishes infection as the dominant cause of death, and so the priority
      for supportive care.
- name: Genetic Counseling
  description: >-
    Autosomal recessive counseling, with carrier testing informative in
    populations carrying the c.155-166del founder allele.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:19554981
    reference_title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All of the parents were heterozygous carriers of this mutation."
    explanation: >-
      Obligate carrier parents with a single recurrent allele make carrier
      testing straightforward in these populations.
animal_models:
- name: pmn/pmn mouse (Tbce p.Trp524Gly)
  species: Mouse
  genotype: Tbce c.1570T>G p.(Trp524Gly), homozygous (progressive motor neuronopathy allele)
  publication: PMID:12389029
  description: >-
    The only established Tbce animal model, and it is a spontaneous mouse
    mutant that was studied as a motor neuron disease model for a decade before
    the human gene was identified. It carries a substitution at the terminal
    residue of Tbce that destabilizes the protein - mechanistically the same
    class of lesion as the human disease - and it reproduces the microtubule
    deficit faithfully. It does not reproduce the human syndrome: pmn mice
    develop progressive motor axon degeneration and die at four to six weeks,
    while human HRD patients have hypoparathyroidism, primordial growth failure
    and immunodeficiency without a motor neuronopathy. The model is therefore
    informative about what TBCE does to microtubules and uninformative about why
    the human parathyroid fails.
  modeled_mechanisms:
  - target: Loss of Tubulin-Folding Cofactor E
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >-
      A destabilizing missense allele reducing Tbce protein, complemented by a
      wild-type transgene - the causal relationship is established rather than
      correlative.
    limitations: >-
      A single missense allele at the extreme C-terminus, not the human
      12-base-pair deletion, and studied in a species where the resulting
      phenotype is a motor neuronopathy.
    readouts:
    - name: Rescue of phenotype by wild-type Tbce transgene
      target: Loss of Tubulin-Folding Cofactor E
      direction: RESTORED
      interpretation: >-
        Transgenic complementation restoring a normal phenotype establishes
        that Tbce loss is the cause rather than a linked marker.
      evidence:
      - reference: PMID:12389029
        reference_title: "A missense mutation in Tbce causes progressive motor neuronopathy in mice."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Transgenic complementation with a wildtype Tbce cDNA restored a normal phenotype in mutant mice."
        explanation: Establishes causality by rescue.
    evidence:
    - reference: PMID:12389029
      reference_title: "A missense mutation in Tbce causes progressive motor neuronopathy in mice."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "we identify the pmn mutation as resulting in a Trp524Gly substitution at the last residue of the tubulin-specific chaperone e (Tbce) protein that leads to decreased protein stability"
      explanation: >-
        Identifies the model's lesion as a destabilizing Tbce allele, the same
        class of defect as the human disease.
  - target: Reduced Microtubule Density and Perturbed Polarity
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      Microtubule loss is demonstrated directly in mutant nerve, and the later
      study localizes TBCE to the Golgi and shows that microtubule loss proceeds
      retrogradely in step with axonal dying back - a cell-biological account of
      the cytoskeletal defect that the human patient-cell data can only measure
      statically.
    limitations: >-
      Measured in motor axons, a compartment not implicated in the human
      disease; whether parathyroid or lymphoid cells show the same defect in
      vivo is untested.
    readouts:
    - name: Axonal microtubule number in sciatic and phrenic nerve
      target: Reduced Microtubule Density and Perturbed Polarity
      direction: DECREASED
      interpretation: >-
        Direct structural confirmation that Tbce loss depletes microtubules in
        vivo.
      evidence:
      - reference: PMID:12389029
        reference_title: "A missense mutation in Tbce causes progressive motor neuronopathy in mice."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Electron microscopy of the sciatic and phrenic nerves of affected mice showed a reduced number of microtubules, probably due to defective stabilization."
        explanation: The structural measurement behind this readout.
    evidence:
    - reference: PMID:17699660
      reference_title: "Progressive motor neuronopathy: a critical role of the tubulin chaperone TBCE in axonal tubulin routing from the Golgi apparatus."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "In pmn mice, TBCE is destabilized and disappears from the Golgi apparatus of motor neurons, and microtubules are lost in distal axons."
      explanation: >-
        Connects the destabilized protein, its subcellular site of action, and
        the microtubule loss in the same model.
  - target: Disturbed Microtubule-Dependent Membrane Trafficking
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    description: >-
      The model supplies the mechanistic content this node otherwise lacks:
      TBCE is a peripheral membrane protein at the Golgi, and disrupting the
      Golgi pharmacologically phenocopies the mutation's effect on tubulin
      routing. That makes a Golgi-centred trafficking defect a demonstrated
      mechanism in neurons rather than only a proposal.
    limitations: >-
      Shown for tubulin routing in motor neurons. The human node concerns
      secretory trafficking in parathyroid cells, which this model does not
      address at all - the parathyroid phenotype is absent in pmn mice.
    readouts:
    - name: Axonal tubulin routing from the Golgi apparatus
      target: Disturbed Microtubule-Dependent Membrane Trafficking
      direction: DECREASED
      interpretation: >-
        Three independent perturbations converging on the same defect place
        TBCE in a Golgi-dependent tubulin-routing pathway.
      evidence:
      - reference: PMID:17699660
        reference_title: "Progressive motor neuronopathy: a critical role of the tubulin chaperone TBCE in axonal tubulin routing from the Golgi apparatus."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "In cultured motor neurons, the pmn mutation, interference RNA-mediated TBCE depletion, and brefeldin A-mediated Golgi disruption all compromise axonal tubulin routing."
        explanation: The convergent evidence behind this readout.
    evidence:
    - reference: PMID:17699660
      reference_title: "Progressive motor neuronopathy: a critical role of the tubulin chaperone TBCE in axonal tubulin routing from the Golgi apparatus."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "We demonstrate that TBCE is a peripheral membrane-associated protein that accumulates at the Golgi apparatus."
      explanation: >-
        Localizes TBCE to the compartment this node concerns, which is what
        makes the model partially informative for it.
  - target: Parathyroid Failure and Congenital Hypoparathyroidism
    relationship: FAILS_TO_RECAPITULATE
    fidelity: LOW
    description: >-
      pmn mice have no reported hypoparathyroidism. The defining endocrine
      feature of the human disease is absent from the only Tbce model, so the
      step from a general cytoskeletal defect to selective parathyroid
      aplasia has no animal support.
    limitations: >-
      The mouse phenotype is a progressive motor neuronopathy with death at
      four to six weeks - a lethal course in a compartment the human disease
      spares, and possibly too early for a parathyroid phenotype to be
      ascertained. The published characterizations do not report parathyroid
      assessment either way, so this is an absence of evidence in a model whose
      overall phenotype is clearly divergent, not a documented negative
      parathyroid study.
    evidence:
    - reference: PMID:12389029
      reference_title: "A missense mutation in Tbce causes progressive motor neuronopathy in mice."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Mice that are homozygous with respect to the progressive motor neuronopathy (pmn) mutation (chromosome 13) develop a progressive caudio-cranial degeneration of their motor axons from the age of two weeks and die four to six weeks after birth."
      explanation: >-
        The full reported phenotype of the model is a motor neuronopathy; no
        endocrine feature is described, which is the divergence this link
        records.
references:
- reference: PMID:12389028
  title: "Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome."
- reference: PMID:19554981
  title: "Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait."
- reference: PMID:42433342
  title: "Sanjad-Sakati Syndrome in Jordan: Clinical Features, Comorbidities, and Mortality Rate."
- reference: PMID:30638765
  title: "Additional Tunisian patients with Sanjad-Sakati syndrome: A review toward a consensus on diagnostic criteria."
- reference: PMID:36258138
  title: "Hypoparathyroidism-Retardation-Dysmorphism Syndrome due to a Variant in the Tubulin-Specific Chaperone E Gene as a Cause of Combined Immune Deficiency."
- reference: PMID:12389029
  title: "A missense mutation in Tbce causes progressive motor neuronopathy in mice."
- reference: PMID:17699660
  title: "Progressive motor neuronopathy: a critical role of the tubulin chaperone TBCE in axonal tubulin routing from the Golgi apparatus."
📚

References & Deep Research

References

7
PMID:12389028
Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome.
No top-level findings curated for this source.
PMID:19554981
Sanjad-Sakati syndrome/Kenny-Caffey syndrome type 1: a study of 21 cases in Kuwait.
No top-level findings curated for this source.
PMID:42433342
Sanjad-Sakati Syndrome in Jordan: Clinical Features, Comorbidities, and Mortality Rate.
No top-level findings curated for this source.
PMID:30638765
Additional Tunisian patients with Sanjad-Sakati syndrome: A review toward a consensus on diagnostic criteria.
No top-level findings curated for this source.
PMID:36258138
Hypoparathyroidism-Retardation-Dysmorphism Syndrome due to a Variant in the Tubulin-Specific Chaperone E Gene as a Cause of Combined Immune Deficiency.
No top-level findings curated for this source.
PMID:12389029
A missense mutation in Tbce causes progressive motor neuronopathy in mice.
No top-level findings curated for this source.
PMID:17699660
Progressive motor neuronopathy: a critical role of the tubulin chaperone TBCE in axonal tubulin routing from the Golgi apparatus.
No top-level findings curated for this source.

Deep Research

1
Claude Code ▸
Sanjad–Sakati Syndrome (Hypoparathyroidism–Retardation–Dysmorphism Syndrome): Comprehensive Research Report
claude-haiku-4-5-20251001, claude-sonnet-5 32 citations 2026-08-27T01:50:08.139019

Sanjad–Sakati Syndrome (Hypoparathyroidism–Retardation–Dysmorphism Syndrome): Comprehensive Research Report

1. Disease Information

Overview. Sanjad–Sakati syndrome (SSS), also known as Hypoparathyroidism–Retardation–Dysmorphism (HRD) syndrome or "Middle East syndrome," is a rare autosomal recessive multisystem disorder first described in Saudi Arabia in 1988 and formally reported in 1991 by Sanjad, Sakati, Abu-Osba, Kaddoura, and Milner in Archives of Disease in Childhood ("A new syndrome of congenital hypoparathyroidism, severe growth failure, and dysmorphic features," 1991;66:193–196) (Wikipedia; Case Reports in Pediatrics 2014). It is a combined-immunodeficiency, multiple-congenital-anomaly syndrome caused by biallelic loss-of-function mutations in the TBCE gene, characterized by the core tetrad of congenital hypoparathyroidism, severe intrauterine/postnatal growth retardation, characteristic craniofacial dysmorphism, and intellectual disability (PMC7377659; Orphanet).

Key identifiers: - OMIM: 241410 (Hypoparathyroidism, Retardation, and Dysmorphism; HRD/HRDS) - Orphanet: ORPHA2323 - MONDO: MONDO:0009426 - Gene (OMIM): TBCE, 604934 - Disease Ontology: DOID:0060348 - MeSH/synonyms: Kenny-Caffey syndrome, autosomal recessive (allelic disorder); Richardson-Kirk syndrome (older name in some literature)

Common synonyms: Sanjad-Sakati syndrome; Hypoparathyroidism-Retardation-Dysmorphism syndrome (HRD/HRDS); Hypoparathyroidism-intellectual disability-dysmorphism; Kenny-Caffey syndrome type 1 (allelic, TBCE-related — note this is now understood to be a related but clinically distinct entity, not a synonym); "Middle East syndrome."

Source of information. Knowledge is derived predominantly from aggregated case series and cohort studies (the largest cohorts are 12–56 patients from Saudi Arabia, Oman, Qatar, Kuwait, Jordan, and other Middle Eastern/North African countries) rather than large-scale EHR data, reflecting the disease's rarity and geographic concentration (PMC3191633; Frontiers 2026).

2. Etiology

Disease causal factors. SSS is caused by biallelic (homozygous or compound heterozygous) loss-of-function mutations in TBCE (tubulin-folding cofactor E; chromosome 1q42.3), a purely genetic/monogenic disease with autosomal recessive inheritance. There is no known environmental or infectious primary cause; environmental/infectious factors act only as secondary morbidity/mortality drivers in already-affected individuals (see Prognosis, §11).

Genetic risk factors: - Causal variant: The predominant pathogenic allele in Middle Eastern populations is a founder 12-base-pair deletion in exon 3 of TBCE — variably described as c.155_166del (p.Ser52_Gly55del) or "155–166del" — identified as homozygous in essentially all classic Saudi, Qatari, Kuwaiti, Omani, and other Gulf-region patients (Nature Genetics, Parvari et al. 2002, PMID:12389028; Frontiers 2026). - Consanguinity is the dominant genetic/demographic risk factor: SSS is seen "predominantly [in] consanguineous parents" and is essentially restricted to populations with high consanguinity rates in the Middle East/Arabian Gulf (WebSearch summary). - Modifier genes: No established modifier loci; however, one report (Courtens et al. 2006, Am J Med Genet A, PMID:16470743) describes an HRD-phenotype "variant not caused by a TBCE mutation," implying possible locus heterogeneity or phenocopies in a minority of cases (Wiley). - Allelic disorders at the same locus: Different TBCE mutations cause a spectrum — HRD/SSS, autosomal recessive Kenny-Caffey syndrome type 1 (KCS1), and progressive encephalopathy with amyotrophy and optic atrophy (PEAMO, OMIM 617207) — indicating genotype-phenotype correlation by mutation type/severity (PMID:12389028).

Environmental risk factors: None established as causal. Consanguineous marriage practice is a population-level cultural/social risk factor for homozygosity, not an environmental toxin/exposure per se.

Protective factors: None specific to disease occurrence are documented (this is a fully penetrant monogenic recessive disorder in homozygotes); however, early diagnosis/aggressive calcium-vitamin D management and infection-prophylaxis programs are protective against the syndrome's major morbidity/mortality (see §13).

Gene-environment interactions: Not applicable/not documented — SSS is essentially deterministic given biallelic pathogenic TBCE genotype; environmental factors (primarily infectious exposure) modulate morbidity/mortality rather than disease occurrence.

3. Phenotypes

Phenotype frequencies below (percentages) are drawn primarily from the 2026 Frontiers narrative review synthesizing multiple cohort studies, and cohort papers on Omani/immune-phenotyping/ophthalmology series (Frontiers 2026; PMC9579628, PMID:36258138).

Endocrine

Phenotype HPO term (suggested) Onset Frequency/notes
Congenital hypoparathyroidism HP:0008207 Congenital hypoparathyroidism / HP:0000829 Hypoparathyroidism Neonatal/early infancy Near-universal (defining feature); PTH 0.4–7.5 pg/mL
Hypocalcemic seizures/tetany HP:0002153 Hypocalcemia; HP:0032792 Neonatal seizure Neonatal-infancy Hallmark presenting event; serum calcium 5–7 mg/dL
Hyperphosphatemia HP:0002905 Hyperphosphatemia Infancy Serum phosphorus 6.4–13 mg/dL
Hypothyroidism HP:0000821 Hypothyroidism Variable ~36% of cases
Adrenal glucocorticoid insufficiency HP:0008163 Decreased circulating cortisol Variable ~22%
Growth hormone deficiency HP:0000824 Growth hormone deficiency Childhood ~28%
Symptomatic hypoglycemia HP:0001943 Hypoglycemia Infancy 55% hospitalization rate

Growth

| Severe intrauterine growth restriction | HP:0001511 Intrauterine growth retardation | Prenatal | Near-universal | | Postnatal growth retardation / short stature | HP:0008897 Postnatal growth retardation; HP:0004322 Short stature | Progressive from birth | Near-universal, severe | | Delayed bone age | HP:0002750 Delayed skeletal maturation | Childhood | 91.7% in imaging cohorts |

Craniofacial dysmorphism

Long, narrow face (HP:0000276), deep-set/small eyes (HP:0000490 Deeply set eye), beaked nose (HP:0000426 Prominent nose / HP:0011804 Convex nasal ridge), large floppy/posteriorly rotated ears (HP:0000410 Prominent antihelix / HP:0000368 Low-set ears / HP:0009237), long philtrum (HP:0000343), thin upper lip vermilion (HP:0000219), micrognathia (HP:0000347), high forehead (HP:0000348), microcephaly (HP:0000252). These are congenital and stable/non-progressive.

Neurological

  • Mild-to-moderate (occasionally severe) intellectual disability (HP:0001249) — nearly universal, exacerbated by recurrent hypocalcemic seizures.
  • Recurrent seizures (HP:0001250) — common, largely hypocalcemia-driven but can persist.
  • Microcephaly, intracranial (basal ganglia/globus pallidus) calcifications (HP:0002514 Basal ganglia calcification) — ~29% of imaged cases.
  • Reduced white matter volume — ~30% of imaged cohorts.
  • Ventriculomegaly (HP:0002119), spinal canal stenosis (HP:0008421).

Ophthalmologic

A dedicated cohort of 17 children found microphthalmia/nanophthalmos and retinal vascular tortuosity in essentially all patients; esotropia 47%, exotropia 23%, significant hyperopic astigmatism 94%; corneal opacification/clouding also reported (eyewiki.org). Suggested HPO terms: HP:0000568 Microphthalmia, HP:0000501 Glaucoma (if present), HP:0000640 Tortuosity of retinal arteries, HP:0007957 Corneal opacity, HP:0000508 Ptosis (variable), HP:0000077 Astigmatism.

Respiratory

Obstructive sleep apnea reported in all cases of a 12-patient genetically confirmed Omani series; central apnea/sleep-related hypoventilation in 33%; two patients developed pulmonary hypertension and died of type II respiratory failure (Frontiers 2026; PMC3191633). Recurrent respiratory infections are a canonical HPO term for this disease (HP:0002205).

Renal

Bilateral medullary nephrocalcinosis in 59% of a 17-patient cohort (up to 67% in a 24-patient renal ultrasound cohort), with progression to end-stage renal disease in at least one reported case.

Gastrointestinal

GERD in ~27.2% of a phenotyped cohort; intestinal obstruction/superior mesenteric artery (SMA) syndrome has been reported as a rare complication, the first such association described by AlAyed et al. 2014 (Case Reports in Pediatrics, PMID:25436165) (PMC4241564).

Dental

Systematic review of 56 SSS cases found enamel hypoplasia, hypodontia, microdontia, small dental arches, and deep overbite as recurrent findings (PMC3600134).

Immune/Hematologic

See §6 (Immune mechanism) below; also macrocytic anemia and failure to thrive reported in case reports (e.g., a South Jordan case, PMID:29494340).

Skeletal

Small hands/feet (HP:0200055 Small hand; short foot), long tapering fingers with clinodactyly, patchy osteosclerosis, medullary stenosis of long bones (shared with the allelic Kenny-Caffey spectrum, though classic SSS skeletal involvement is milder than KCS).

Quality of life impact: Not formally measured with standardized instruments (EQ-5D/SF-36) in the literature reviewed; qualitatively, the combination of intellectual disability, recurrent hospitalization for metabolic crises/infections, and high early mortality represents a severe, life-limiting burden with substantial caregiver and health-system impact, particularly in resource-limited settings.

4. Genetic/Molecular Information

Causal gene: TBCE (Tubulin Folding Cofactor E), HGNC:11582, OMIM *604934, chromosome 1q42.3 (locus spans ~230 kb) (Wikipedia; OMIM 604934).

Pathogenic variants: - Founder variant: 12-bp deletion in exon 3 (c.155_166del; p.Ser52_Gly55del), homozygous in essentially all classic Middle Eastern SSS patients — a striking single-founder-mutation pattern consistent with a common ancestral haplotype in the Gulf region (PMID:12389028). - Variant type/class: In-frame small deletion (classic founder allele); other reported TBCE mutations across the allelic spectrum (SSS/HRD, KCS1, PEAMO) include additional missense, splice-site, and truncating variants, generally understood as loss-of-function or severely hypomorphic alleles. - Functional consequence: Loss-of-function — reduced/absent TBCE (cofactor E) chaperone activity, defective α-tubulin folding and microtubule assembly/stability. - Zygosity: Homozygous (founder deletion) or compound heterozygous in non-founder-population cases. - Somatic vs. germline: Germline (constitutional), consistent with a classic Mendelian recessive disorder. - Allele frequency: Specific gnomAD/population carrier-frequency figures for the TBCE 12-bp deletion were not identified in available sources (a known data gap); the disorder is essentially restricted to Middle Eastern/Arab-descent populations, and general Arab-population carrier-screening literature exists (e.g., "Pathogenic variation underlying rare diseases in an Arab population," 2025) but did not surface TBCE-specific figures in this search.

Molecular mechanism: TBCE is one of five tubulin-specific chaperones (cofactors A–E) that mediate ordered α/β-tubulin heterodimer folding and assembly. Cofactors A and D capture/stabilize a quasi-native β-tubulin intermediate; TBCE binds the cofactor-D/β-tubulin complex; interaction with cofactor C then promotes release of correctly folded β-tubulin polypeptides (search synthesis; GeneCards TBCE). Loss of TBCE activity causes defective tubulin heterodimer formation, microtubule instability, and downstream disruption of microtubule-dependent processes (secretory vesicle trafficking, Golgi organization, axonal transport) across multiple cell types, explaining the multisystem phenotype.

Epigenetic information: No disease-specific epigenetic (DNA methylation/histone) studies were identified in the search.

Chromosomal abnormalities: Not applicable — SSS is caused by intragenic point/small deletion mutations, not large-scale chromosomal rearrangements.

5. Environmental Information

No primary environmental, lifestyle, or infectious causal factors are documented for SSS itself (a purely monogenic disorder). Infectious agents (notably encapsulated bacteria — Streptococcus pneumoniae and other organisms — plus viral pathogens including SARS-CoV-2) are important secondary morbidity/mortality drivers in affected children due to the syndrome's combined immunodeficiency (see §6, §11) rather than causal agents of the syndrome itself (Frontiers 2026).

6. Mechanism / Pathophysiology

Causal chain (upstream → downstream): 1. Molecular trigger: Biallelic TBCE loss-of-function mutation (founder 12-bp exon 3 deletion) → loss/reduction of tubulin-folding cofactor E activity. 2. Protein/cellular dysfunction: Defective α-tubulin folding and impaired α/β-tubulin heterodimer formation → microtubule instability and reduced microtubule density, particularly at the microtubule-organizing center (MTOC); disturbed microtubule polarity. 3. Organelle/trafficking consequences: Disruption of microtubule-dependent membrane trafficking, including Golgi apparatus structure and late endosomal compartments — demonstrated in patient fibroblasts and lymphoblastoid cell lines, and mechanistically in the mouse pmn (progressive motor neuronopathy) model where TBCE is destabilized and lost from the neuronal Golgi apparatus, with retrograde ("dying-back") loss of axonal microtubules (J Neurosci 2007, PMID:17699660; J Cell Biol 2002). 4. Tissue-specific manifestations: - Parathyroid gland: Impaired PTH synthesis/secretory trafficking → congenital hypoparathyroidism → hypocalcemia/hyperphosphatemia → tetany, seizures, and downstream basal ganglia calcification. - Skeletal growth plate/osteoblasts: Microtubule-dependent processes in chondrocyte/osteoblast function contribute to severe growth retardation and (in the allelic Kenny-Caffey spectrum) medullary bone stenosis. - Craniofacial development: Disrupted cytoskeletal dynamics during craniofacial morphogenesis produce the characteristic dysmorphic facies. - CNS: Neuronal microtubule dysfunction (analogous to the axonal transport defect in pmn mice) plausibly contributes directly to intellectual disability/developmental delay independent of hypocalcemic seizure burden, though the precise relative contribution is not fully resolved in humans. - Immune system: A 2022 immune-phenotyping study (PMID:36258138) established SSS/HRD as a cause of combined immunodeficiency: abnormal T-cell subset distributions (reduced terminally differentiated effector-memory CD8+ T cells, inverted CD4/CD8 ratio), impaired PHA-induced lymphocyte proliferation, elevated total IgA/IgE, low anti-pneumococcal antibody titers despite vaccination, reduced naive B cells with expanded CD21^low^CD27^−^ B cells — a phenotype attributable to microtubule-dependent defects in immune-cell cytoskeletal function (immune synapse formation, vesicular trafficking, proliferation) (PMC9579628).

Cell types involved (suggested CL terms): parathyroid chief cell (CL:1000696 / CL:0000512), CD8-positive alpha-beta T cell (CL:0000625), CD4-positive alpha-beta T cell (CL:0000624), naive B cell (CL:0000788), osteoblast (CL:0000062), chondrocyte (CL:0000138), motor neuron (CL:0000100, per mouse model relevance).

Biological processes (suggested GO terms): GO:0007021 tubulin complex assembly; GO:0000226 microtubule cytoskeleton organization; GO:0030163 protein catabolic process (N/A); GO:0006888 ER-to-Golgi vesicle-mediated transport; GO:0030496 midbody (structural, N/A); most relevantly GO:0007023 post-chaperonin tubulin folding pathway and GO:0051258 protein polymerization.

Molecular function (suggested GO term): GO:0048487 beta-tubulin binding; unfolded protein binding (chaperone activity).

Model system evidence: The mouse pmn/pmn (progressive motor neuronopathy) model carries a missense Tbce mutation (Trp524Gly) causing destabilized TBCE protein, motor neuron axonal microtubule loss, progressive motoneuron disease, skeletal muscle weakness, and death by respiratory failure around postnatal week 3-4 — an informative but imperfect model, since it recapitulates the axonal/neuromuscular consequences of TBCE loss but does not model the parathyroid/craniofacial/growth phenotype, and represents a hypomorphic missense allele rather than the human founder deletion (Nature Genetics 2002, PMID:12389029; J Cell Biol 2002). A related paper also documents TBCE-mutant-mouse cochlear outer hair cell degeneration and progressive hearing loss via auditory nerve microtubule disturbance (PMID:24120439), suggesting audiological screening may be underappreciated in human SSS.

Omics/advanced technologies: No transcriptomic, proteomic, single-cell, or spatial-omics studies specific to SSS/TBCE patient tissue were identified in this search — a notable knowledge gap for future systems-level characterization.

7. Anatomical Structures Affected

  • Organ level (primary): Parathyroid glands (aplasia/hypoplasia/dysfunction), skeletal system (growth plates, long bones), craniofacial skeleton, brain, eyes, teeth.
  • Organ level (secondary/complications): Kidneys (nephrocalcinosis), lungs/upper airway (OSA, pulmonary hypertension), gastrointestinal tract (SMA syndrome, GERD), immune organs (thymus/lymphoid tissue — combined immunodeficiency).
  • Body systems: Endocrine, skeletal/musculoskeletal, nervous, ophthalmic, renal, respiratory, gastrointestinal, immune.
  • Tissue/cell level: Parathyroid chief cells, chondrocytes/osteoblasts, craniofacial neural-crest-derived mesenchyme, cortical/subcortical neurons, retinal vasculature and corneal epithelium, T- and B-lymphocyte subsets, dental enamel-forming ameloblasts.
  • Subcellular level: Microtubule cytoskeleton and MTOC (GO:0005815 microtubule organizing center); Golgi apparatus (GO:0005794) and late endosomal compartments — the principal subcellular sites of TBCE-dependent dysfunction.
  • Localization/laterality: Craniofacial and skeletal features are typically bilateral/symmetric; nephrocalcinosis reported as bilateral in the majority of renal cases; basal ganglia calcifications are typically bilateral (globus pallidus).

Suggested UBERON terms: UBERON:0001132 (parathyroid gland), UBERON:0002037 (cerebellum, if relevant to imaging findings), UBERON:0002420 (basal ganglion), UBERON:0002113 (kidney), UBERON:0000970 (eye), UBERON:0003129 (skull).

8. Temporal Development

  • Onset: Congenital/prenatal (severe IUGR is present at birth); hypoparathyroidism manifests in early infancy (often the presenting event, via hypocalcemic seizures/tetany in the neonatal period or first weeks of life).
  • Onset pattern: Acute presenting events (hypocalcemic seizures, sepsis) superimposed on a chronic, congenital multisystem disorder.
  • Progression: Growth retardation and dysmorphism are present from birth and largely non-progressive in structural terms, but endocrine/metabolic complications (hypothyroidism, adrenal insufficiency, growth hormone deficiency) can emerge over childhood; nephrocalcinosis, renal impairment, sleep-disordered breathing/pulmonary hypertension, and neurodevelopmental sequelae accumulate progressively over childhood and adolescence.
  • Disease course pattern: Chronic and lifelong, punctuated by recurrent acute crises (hypocalcemia, infection, seizures) requiring hospitalization — a relapsing pattern of acute decompensation against a stable structural/developmental baseline.
  • Critical periods: The neonatal-to-infancy period is the critical window for both diagnosis (recognizing the hypocalcemic-seizure presentation) and intervention (early, aggressive calcium/vitamin D repletion appears to influence long-term neurodevelopmental and growth outcomes).
  • Remission patterns: No spontaneous remission (monogenic structural/endocrine disorder); acute hypocalcemic/infectious episodes are treatment-responsive but the underlying hypoparathyroidism is lifelong.

9. Inheritance and Population

  • Inheritance pattern: Autosomal recessive, full penetrance in homozygotes/compound heterozygotes for pathogenic TBCE alleles.
  • Epidemiology: Estimated incidence in Saudi Arabia is reported inconsistently across sources — approximately 1 in 100,000 live births per the 2026 Frontiers review, versus a wider range of 1 in 40,000 to 1 in 600,000 cited elsewhere, reflecting genuine regional/study heterogeneity and small denominators rather than a single settled figure (Frontiers 2026; search synthesis). Comparable prevalence is reported across other Gulf Cooperation Council countries.
  • Consanguinity: A dominant epidemiological driver — the overwhelming majority of reported cases occur in children of consanguineous Middle Eastern parents.
  • Founder effect: Essentially all classic cases share the identical homozygous 12-bp exon 3 TBCE deletion, indicating a strong single-founder-haplotype effect that likely arose and expanded within Arabian Peninsula populations, consistent with a shared ancestral chromosome (PMID:12389028).
  • Carrier frequency: No specific quantitative carrier-frequency figure for the TBCE founder deletion was identified in the sources searched (a documented gap; general Arab-population carrier-screening literature exists but did not yield a TBCE-specific rate in this search).
  • Population demographics: Reported almost exclusively in individuals of Arab/Middle Eastern descent — Saudi Arabia (index population), Qatar, Kuwait, Oman, Jordan, Iraq, Sudan, Morocco, Tunisia — with rare cases described "beyond the Middle East" in diaspora populations and non-Arab ethnicities (see Courtens et al. 2006 TBCE-negative HRD-phenotype case, suggesting either broader geographic spread of the founder allele via migration, or genuine locus heterogeneity in atypical cases) (ResearchGate: "Sanjad-Sakati syndrome: Beyond the Middle-East").
  • Sex ratio: No clear sex predilection is reported (consistent with autosomal, not X-linked, inheritance).

10. Diagnostics

Biochemical findings (Table synthesized from Frontiers 2026 review):

Parameter Typical finding
Serum calcium Decreased (5–7 mg/dL reported range)
Serum phosphate Elevated (6.4–13 mg/dL)
PTH Inappropriately low/undetectable (0.4–7.5 pg/mL)
Serum magnesium Normal or low
Alkaline phosphatase Normal or slightly elevated

Imaging: - Cranial CT/MRI: basal ganglia/globus pallidus calcifications (~29%), pituitary hypoplasia, corpus callosum abnormalities, reduced white matter volume (~30%). - Skeletal radiographs: delayed bone age (91.7%), medullary stenosis (8.3%, overlapping with the allelic Kenny-Caffey spectrum), patchy osteosclerosis. - Renal ultrasound: nephrocalcinosis (59–67% depending on cohort).

Genetic testing: Molecular confirmation via TBCE sequencing/deletion testing is diagnostic; the founder 12-bp exon 3 deletion accounts for the great majority of Middle Eastern cases and can be specifically targeted (e.g., by PCR/fragment analysis) in populations with known founder-mutation prevalence, with broader gene-panel or exome sequencing reserved for atypical/non-founder cases.

Clinical diagnostic criteria: No formal consensus society diagnostic-criteria document (e.g., DSM/ICD-style) was identified; diagnosis rests on the clinical tetrad (hypoparathyroidism + severe growth failure + dysmorphism + developmental delay) in a patient of Middle Eastern/consanguineous background, confirmed by biochemistry and TBCE molecular testing.

Differential diagnosis: The principal differential is the allelic disorder autosomal recessive Kenny-Caffey syndrome (type 1, TBCE-related), which shares the parathyroid/growth/craniofacial phenotype but is distinguished by normal intelligence and a distinct, more prominent skeletal phenotype (cortical thickening/medullary stenosis of long bones, delayed fontanel closure) — SSS/HRD is distinguished by prominent intellectual disability as a core feature (search synthesis of PMID:12389028 and Orphanet). Other syndromic hypoparathyroidism disorders (e.g., DiGeorge/22q11.2 deletion syndrome, autoimmune polyendocrinopathy syndrome type 1/APECED, Barakat/HDR syndrome) should be considered and excluded, particularly in atypical or non-Middle-Eastern presentations.

Screening: No dedicated national newborn-screening program for SSS/TBCE was identified; given the strong founder-mutation effect, targeted premarital/carrier or prenatal molecular screening in high-risk consanguineous Gulf populations is a plausible but not confirmed-in-literature public-health strategy in this search.

11. Outcome/Prognosis

Mortality: Reported mortality is high and variable by cohort. The Frontiers 2026 review states that "in the largest longitudinal cohort, mortality was 52%, with pneumonia, septic shock, and meningitis accounting for most deaths" (Frontiers 2026). Similarly, the 2022 immune-phenotyping cohort reported "all but one patient died from infections, which included septic shock, meningitis, and pneumonia" (PMID:36258138), underscoring that infection — driven by the underlying combined immunodeficiency — is the dominant cause of death, rather than hypocalcemia itself once biochemical management is established. Respiratory complications (obstructive sleep apnea progressing to pulmonary hypertension and type II respiratory failure) are a second major cause of death in some series.

Morbidity: Persistent neurodevelopmental delay, short stature, and variable intellectual disability typically persist despite optimal biochemical management; renal, respiratory, ophthalmologic, and dental morbidity accumulate over childhood.

Prognostic factors: Severity/timeliness of correction of hypocalcemia, extent of multiorgan involvement, and adequacy of infection prophylaxis/supportive care are the principal modifiable determinants of outcome cited in the literature.

Complications: Nephrocalcinosis (up to end-stage renal disease in reported cases), pulmonary hypertension, recurrent bacteremia/sepsis (including fatal COVID-19 in at least two reported patients), superior mesenteric artery syndrome/intestinal obstruction, basal ganglia calcification-associated neurological deficits.

Quality of life: Not formally quantified with standardized PROMs in the literature reviewed, but the disease burden (recurrent hospitalization, intellectual disability, high mortality) is substantial.

12. Treatment

Pharmacotherapy (mainstay): - Calcium supplementation: ~50–75 mg/kg/day elemental calcium. - Active vitamin D analogues: calcitriol or alfacalcidol, ~0.25–1 μg/day (NCIT: pharmacotherapy, NCIT:C15986; the specific agents map to CHEBI terms — calcitriol CHEBI:17823). - Magnesium supplementation: ~50–100 mg/kg/day magnesium oxide when hypomagnesemia present. - Phosphate binders: calcium-based agents or sevelamer hydrochloride when dietary phosphate restriction is insufficient. - Growth hormone supplementation: offered in some cohorts for growth hormone deficiency, though data on efficacy specific to SSS growth outcomes are limited (Hindawi 2014 case report; NCIT:C29688 or generic pharmacotherapy term).

Advanced/novel therapeutics: - Recombinant PTH (subcutaneous/continuous pump infusion): A 2024 case report (Bali & Al Khalifah, JCEM Case Reports) documents recombinant PTH used in a neonate with SSS refractory to conventional calcium/vitamin D therapy — subcutaneous injections titrated from 1 to 1.5 mcg/kg/day, then transitioned to continuous subcutaneous pump infusion (0.125 mcg/hour, 3 mcg/day total) via a Medtronic MiniMed Vio pump. This "successfully weaned the patient off continuous IV calcium infusion," and after managing transient iatrogenic hypercalcemia, calcium/vitamin D requirements fell by over 50% and remained stable for six years — the authors concluding "PTH subcutaneous infusion can be highly effective in refractory hypocalcemia cases and can significantly impact the treatment course and facilitate hospital discharge" (JCEM Case Reports 2024). This represents the most notable recent (2024) therapeutic development for this disease. Relevant NCIT term: Pharmacotherapy (NCIT:C15986); therapeutic agent: recombinant human parathyroid hormone.

Supportive/rehabilitative care: - Seizure management (anticonvulsants during acute hypocalcemic seizures). - Infection prophylaxis: prophylactic antibiotics have been used in cohorts given the combined immunodeficiency, though "despite prophylactic antibiotics, the cohort exhibited considerable infectious morbidity." - Multidisciplinary supportive/rehabilitative care: physical therapy, occupational therapy, speech therapy, individualized education plans for developmental delay (NCIT:C15302 Physical Therapy, NCIT:C121351 Occupational Therapy, NCIT:C159273 Speech Therapy). - Dental management protocols tailored to enamel hypoplasia/malocclusion (case reports document individualized dental care, e.g., in Tunisian and other pediatric cases). - Airway management: video laryngoscopy and multidisciplinary anesthesia planning for surgical procedures given craniofacial airway anomalies (relevant for any surgical intervention, e.g., NCIT:C15329 Surgical Procedure). - Renal monitoring/management for nephrocalcinosis; ophthalmologic surveillance and correction (refraction, strabismus surgery) for the ocular phenotype.

Experimental treatments: No disease-specific gene therapy, cell therapy, or targeted molecular therapy trials were identified in this search; management remains predominantly supportive/replacement-based. Given the underlying microtubule-chaperone defect, no small-molecule TBCE-restorative therapy has been reported.

Monitoring: Serum calcium, phosphate, magnesium, and PTH every 2 weeks initially, then quarterly when stable; urinary calcium-to-creatinine ratio; renal ultrasound every 6 months; periodic thyroid and adrenal function testing. Therapeutic targets: low-normal serum calcium (8.0–8.5 mg/dL), upper-normal-to-mildly-elevated phosphate (4.5–5.5 mg/dL), calcium-phosphate product <55 mg²/dL².

Treatment strategy: A structured multidisciplinary framework (pediatric endocrinology, neurology, nephrology, ophthalmology, dentistry, otolaryngology, immunology, pulmonology) plus genetic counseling and psychosocial support is advocated in the most recent (2026) narrative review as the standard of comprehensive care (Frontiers 2026).

13. Prevention

  • Primary prevention: Genetic counseling regarding consanguinity-associated recurrence risk (25% recurrence risk per pregnancy for two carrier parents) is the principal primary-prevention strategy in high-prevalence populations.
  • Secondary prevention/screening: Targeted carrier testing for the known founder TBCE 12-bp deletion is feasible given the strong founder-mutation effect in Gulf populations, and prenatal diagnosis/preimplantation genetic diagnosis would be technically achievable in families with a known TBCE genotype, though no large-scale population screening program specific to TBCE was documented in the literature surveyed.
  • Tertiary prevention: Early neonatal recognition and rapid correction of hypocalcemia (to reduce seizure-related neurodevelopmental injury), infection-prophylaxis protocols (given combined immunodeficiency), and proactive renal/respiratory/ophthalmologic surveillance to prevent/mitigate nephrocalcinosis, pulmonary hypertension, and vision complications.
  • Genetic counseling: Essential in affected families and extended consanguineous kindreds; recommended given the syndrome's severe morbidity/mortality burden and well-defined Mendelian recurrence risk.
  • Public health: No CDC/WHO-level public health program specific to SSS was identified; management is embedded within general Middle Eastern national genetic-disease/consanguinity-counseling programs (e.g., Saudi premarital screening initiatives), though TBCE-specific inclusion in such panels was not confirmed in this search.

14. Other Species / Natural Disease

  • Taxonomy: No naturally occurring veterinary/companion-animal SSS-like disease was identified in this search.
  • Orthologous gene: Mouse Tbce (chromosome 13) is the principal orthologue studied; human TBCE and mouse Tbce share the tubulin-chaperone function.
  • Natural disease in other species: Not documented — the mouse phenotype described below is an induced/spontaneous laboratory mutant, not a naturally occurring veterinary disease entity (no OMIA entry identified in this search).
  • Comparative biology: The conserved tubulin-cofactor pathway across eukaryotes underlies cross-species relevance of TBCE loss-of-function, but clinical phenotype comparison is limited to the mouse model (below) rather than natural veterinary disease.

15. Model Organisms

Primary model: mouse (Mus musculus), pmn/pmn (progressive motor neuronopathy) mutant. - Model type: Spontaneous/induced genetic mouse model; homozygous missense mutation in Tbce (Trp524Gly, at the terminal residue of the protein), causing decreased protein stability (Nature Genetics 2002, PMID:12389029; J Cell Biol 2002). - Phenotype: Mice are healthy at birth but develop progressive motor neuron disease with severe skeletal muscle weakness and death from respiratory failure by approximately postnatal week 3–4. Mechanistically, TBCE is destabilized and lost from the neuronal Golgi apparatus, with retrograde ("dying-back") axonal microtubule loss in motor neurons, demonstrated by electron microscopy showing reduced microtubule numbers in sciatic and phrenic nerves (J Neurosci 2007, PMID:17699660). - Additional phenotype: A related study (PMID:24120439) demonstrates cochlear outer hair cell degeneration and progressive hearing loss in pmn/pmn mice via disturbed auditory nerve microtubules — a phenotype not yet systematically characterized in human SSS patients and a potential underexplored clinical feature. - Recapitulation/fidelity: The pmn model partially recapitulates the neuromuscular/microtubule-instability consequences of TBCE dysfunction (motor axon degeneration) but does not recapitulate the core human SSS phenotype of hypoparathyroidism, growth failure, or craniofacial dysmorphism, and it carries a different (missense, murine-specific) allele rather than the human founder deletion — an important human-model translational-fidelity caveat. The model is most informative for the neurological/neuromuscular axis of TBCE pathobiology rather than the full multisystem human syndrome. - Applications: Useful for studying microtubule-dependent axonal transport, Golgi-to-axon tubulin trafficking, and motor neuron degeneration mechanisms broadly relevant to TBCE biology; less useful as a direct disease model for endocrine/skeletal/craniofacial/immune aspects of SSS, for which no dedicated genetic mouse model (e.g., a Tbce-null or founder-deletion knock-in mimicking the human allele) was identified in this search — representing a clear gap for future model development (e.g., a conditional/hypomorphic Tbce allele targeting parathyroid or craniofacial neural-crest lineages). - Resources: Model maintained/studied at institutions publishing in Nature Genetics, J Cell Biol, and J Neurosci (see citations above); specific repository stock numbers (JAX/MMRRC) were not retrieved in this search.

No other model organism (zebrafish, Drosophila, C. elegans, iPSC-derived organoid, or cell-line model) specific to TBCE/SSS was identified in this search, though patient-derived fibroblast and lymphoblastoid cell lines have been used ex vivo to demonstrate reduced microtubule density and disturbed Golgi/endosomal trafficking (cited in §6).

Summary of Key Evidence Gaps (for KB curation flagging)

  1. Quantitative carrier frequency of the TBCE founder 12-bp deletion in Gulf/Arab populations — not identified in this search.
  2. No dedicated genetic mouse model replicating the human founder allele or the endocrine/craniofacial phenotype (only the neuromuscular pmn missense model exists).
  3. No omics (transcriptomic/proteomic/single-cell) studies on patient tissue were identified.
  4. Some epidemiological incidence figures are inconsistent across sources (1/100,000 vs. 1/40,000–1/600,000) and should be cited with source-specific attribution rather than as a single consensus number.
  5. Reports of an HRD-phenotype case not caused by TBCE mutation (Courtens et al. 2006) suggest possible locus heterogeneity warranting a HUMAN_MODEL_MISMATCH- or notes-level flag if curated.

Sources

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome Count
References checked 20
Resolved 20
Unresolved (possible confabulation) 0
Unverifiable 0
Quoted claims checked 2
Quoted claims found in source 0
Quoted claims not found in source 2
References weighed for topical relevance 20
On topic 8
Off topic 0

Quotes not found in the cited source

Searched the abstract, any retrieved full text, and the title. A quote drawn from a part of the paper that was not retrieved will appear here too, so check before treating one as invented:

Every one of these was searched against an abstract alone, with no full text retrieved - marked abstract only below. Where full text can be fetched, re-running with it will settle them; where the source publishes only a summary to PubMed, as GeneReviews chapters do, it will not, and the quote has to be checked by hand against the chapter itself.

  • DOI:10.3389/fped.2026.1761285 (abstract only): "in the largest longitudinal cohort, mortality was 52%, with pneumonia, septic shock, and meningitis accounting for most deaths"
  • closest text in source: "Early biochemical correction, cautious airway management, infection prevention, and coordinated multidisciplinary follow-up are critical to improving outcomes and reducing morbidity and mortality"
  • PMID:36258138 (abstract only): "all but one patient died from infections, which included septic shock, meningitis, and pneumonia"
  • closest text in source: "Many patients succumb in infancy to HRD due to overwhelming infections mainly caused by Pneumococcus spp"